Viewing Study NCT01381705


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-02-07 @ 10:52 AM
Study NCT ID: NCT01381705
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2011-06-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View